Target directed enediyne prodrugs: hER and AhR degradation by a synthetic oxo-enediyne

Graham B. Jones, Michael W. Kilgore, Richard S. Pollenz, Aiwen Li, Jude E. Mathews, Justin M. Wright, Robert S. Huber, Patricia L. Tate, Thomas L. Price, Robert P. Sticca

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

An efficient route to oxo-enediynes is presented. A simple oxo-enediyne has been synthesized, which cyclizes to give an isochroman. The agent shows cytotoxicity for ER rich breast cancer cells and a model for its mode of action is proposed.

Original languageEnglish
Pages (from-to)1971-1976
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume6
Issue number16
DOIs
StatePublished - Aug 20 1996

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Target directed enediyne prodrugs: hER and AhR degradation by a synthetic oxo-enediyne'. Together they form a unique fingerprint.

Cite this